Skip to content

Organon OGN Accounts Payable

Accounts Payable at other companies

Pfizer logo
PfizerPFE
$4.51B-14.0%
Amgen logo
AmgenAMGN
$2.94B+22.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$233.3M-4.5%
Biogen logo
BiogenBIIB
$358.5M-8.4%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$170M+4.0%
Viatris logo
ViatrisVTRS
$1.75B-12.0%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's accounts payable?
Organon (OGN) reported accounts payable of $983M in Q1 2026.
How has Organon's accounts payable changed year-over-year?
Organon's accounts payable decreased by 2.3% year-over-year, from $1.01B to $983M.
What is the long-term trend for Organon's accounts payable?
Over 5 years (2020 to 2025), Organon's accounts payable has grown at a 29.7% compound annual growth rate (CAGR), from $259M to $952M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.